期刊文献+

亚甲基四氢叶酸还原酶基因多态性对小剂量甲氨喋呤治疗类风湿关节炎不良反应的影响 被引量:6

Relationship between single nucleotide polymorphism of methylenetetrahydrofolate reductase gene and the side effect of low-dose methotrexate in the treatment of rheumatoid arthritis
下载PDF
导出
摘要 目的探讨亚甲基四氢叶酸还原酶(MTHFR)基因C677T多态性对小剂量甲氨喋呤(MTX)治疗类风湿关节炎的影响。方法收集类风湿关节炎患者治疗前及治疗后0,12,24及48 w的临床表现及实验室指标和不良反应信息,评估疗效。采用实时荧光定量聚合酶链反应(FQ-PCR)方法测定类风湿关节炎患者183例(RA组)及健康对照组100例的MTHFR基因C677T多态性,比较两组间基因型分布及等位基因频率。结果 C677T基因型分布在RA组与健康对照组间差异无统计学意义(P>0.05);C677T各基因型在MTX治疗有效率差异无统计学意义(P>0.05)。TT基因型组肝毒性及血液系统不良反应的发生率明显高于CC基因型组,差异均有统计学意义(P<0.05)。结论 MTHFR基因C677T多态性与RA发病和MTX疗效无关,但与MTX治疗后血液系统不良反应、肝毒性有关联。 Objective To investigate single nucleotide polymorhtism of methylenetetrahydrofolate(MTHFR) reductase gene and its association with the side effect of methotrexate in the treatment of rheumatoid arthritis(RA).Methods The clinical and laboratory data of 183 patients with RA were evaluated before treatment and at 0,12,24,48 weeks after treatment.Efficacy and side effects of medication were also analyzed.Real-time fluorescent quantitative PCR was conducted to test gene mutations in RA patients and 100 healthy controls.Results There was no significant difference in the frenquency of 6777CC,CT,TT between RA patients and the healthy controls(P&gt;0.05).There was no significant difference in the frenquency of 6777CC,CT,TT between the group in which MTX was effective and the other groups in which MTX was not effective(P&gt;0.05).There was significant difference in the frenquency of 6777CC,CT,TT between the group with MTX related adverse effects and group without MTX related adverse effects.The occurrence rate of side effects of MTX in the patients with 677TT was higher than those without mutation(CC)(P&lt;0.05).Conclusion There is no relationship between the pathogenesis of RA and the C677T mutation of MTHFR gene.MTHFR gene C677T mutation is probably one of genetic risk factors for the sidde effects of MTX,such as hepatic toxicity and adverse reactions of the blood system.
出处 《中国临床新医学》 2013年第3期211-214,共4页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 广西卫生厅科研课题(编号:Z2009044) 桂林市科学研究与技术开发项目(编号:20090538)
关键词 类风湿关节炎 亚甲基四氢叶酸还原酶基因 单核苷酸多态性 甲氨喋呤 不良反应 Rheumatoid arthritis(RA) Methylenetetrahydrofolate reductase gene Single nucleotide polymorphism Methotrexate(MTX) Adverse reaction
  • 相关文献

参考文献8

  • 1Wessels JA, de Vries-Bonwstro JK, Heijmans BT, et al. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-muclcotide polymorphism in genes coding for folate parth- way enzymes[ J ]. Arthritis Rheum ,2006,54(4 ) : 1087 - 1095. 被引量:1
  • 2Weisman MH, Furst DE, Park GS, et al. Risk genotype in folate-de- pendent enzymes and their association with methotrexae-related side effects in rheumatoid arthritis[ J]. Arthritis Rheum,2006,54(2) :607 -612. 被引量:1
  • 3Hiratsuka M, Kudo M, Knseki N, et al. A novel single nucleotide poly- morphism of the human methylenetetrahydrofolate reductase gene in Japanese individuals [ J ]. Drug Metab Pharmacokinet, 2005,20 ( 5 ) : 387 - 390. 被引量:1
  • 4Frosst P, Blom HI, Milos R, et al. A candidate genetic risk factor for vascular disease:a common mutation in methylenetetrahydrofolate re- ductase[J]. Nat Genet,1995,10(1) :111 -113. 被引量:1
  • 5Wilcken B, Bamforth F, Li Z, et al. Geographical and ethnic variation of the 677C > T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR) :findings from over 7000 newborns from 16 areas world wide [ J ]. J Med Genet ,2003,40 (8) :619 - 625. 被引量:1
  • 6Kumagaik K, Hiyama K, Oyama T, et al. Polymorphisms in the thymi- dylatd synthetase and MTHFR genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis [ J ]. Int J Mol Med,2003,11 ( 5 ) :593 - 600. 被引量:1
  • 7Kim SK, Jun JB, E1-Sonemy A, et al. Cost-effectiveness analysis of MTHFR polymorphism screening by polymerase chain reaction in Ko- rean patients with rheumatoid arthritis receiving methotrexate [ J ]. J Rheumato1,2006,33 (7) : 1266 - 1274. 被引量:1
  • 8杨丽华,刘茹,曾其毅.急性淋巴细胞白血病患儿亚甲基四氢叶酸还原酶基因多态性与大剂量甲氨蝶呤不良反应的相关性[J].实用儿科临床杂志,2012,27(6):440-442. 被引量:28

二级参考文献14

共引文献27

同被引文献55

  • 1杨旭燕,许东航.亚甲基四氢叶酸还原酶基因多态性对甲氨蝶呤不良反应的影响[J].中国药学杂志,2007,42(1):69-72. 被引量:12
  • 2周小妹,徐建华,徐胜前.亚甲基四氢叶酸还原酶基因多态性与甲氨蝶呤治疗类风湿关节炎反应关联性研究进展[J].中华风湿病学杂志,2007,11(8):496-499. 被引量:1
  • 3Varani K, Vincenzi F, Tosi A, et al. Expression and functional role of adenosine receptors in regulating inflammatory responsesin human synoviocytes[J]. Br J Pharmacol, 2010, 160(1): 101- 115. 被引量:1
  • 4Milne GR, Palmer TM. Anti-inflammatory and immunosuppres- sive effects of the A2A adenosine receptor[J]. Sci World J, 2011, 11(1): 320-339. 被引量:1
  • 5Drozdzik M, Rudas T, Pawlik A, et al. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis[J]. Pharmacogenomics J, 2007, 7(6): 404- 407. 被引量:1
  • 6Samara SA, Irshaid YM, Mustafa KN. Association of MDR1 C3435T and RFC1 G80A polymorphisms with methotrexate toxicity and response in jordanian rheuhaatoid arthritis patients[J]. Int J Clin Pharmacol Ther, 2014, 52(9): 746-755. 被引量:1
  • 7?wierkot J, Slszak R, Karpifiski P, et al. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR, TYMS and TC Ⅱ and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis[J]. Pol Arch Med Wewn, 2015, 125(3): 152-161. 被引量:1
  • 8Kato T, Hmuada A, Mori S, et al. Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese pa- tients with rheumatoid arthritis[J]. Drug Metab Pharmacokinet, 2012, 27(2): 192-199. 被引量:1
  • 9Hayashi H, Fujimaki C, Daimon T, et al. Genetic polymor- phisms in folate pathway enzymes as a possible marker for pre- dicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis[J]. J Clin Pharm Ther, 2009, 34(3): 355-361. 被引量:1
  • 10Jekic B, Lukovic L, Bunjevacki V, et al. Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients[J]. Eur J Clin Pharmacol, 2013, 69(3): 377-383. 被引量:1

引证文献6

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部